Exposing Hidden Targets: Combining epigenetic and immunotherapy to overcome cancer resistance
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference97 articles.
1. Nivolumab plus ipilimumab in advanced melanoma;Wolchok;N. Engl. J. Med.,2013
2. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma;Postow;N. Engl. J. Med.,2015
3. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N. Engl. J. Med.,2015
4. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial;Hodi;Lancet Oncol.,2016
5. PD-1 Blockade with pembrolizumab in advanced merkel-cell carcinoma;Nghiem;N. Engl. J. Med.,2016
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Single-cell N6-methyladenosine-related genes function within the tumor microenvironment to affect the prognosis and treatment sensitivity in patients with gastric cancer;Cancer Cell International;2024-01-25
2. New Achievements from Molecular Biology and Treatment Options for Refractory/Relapsed Ovarian Cancer—A Systematic Review;Cancers;2023-11-10
3. A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy;BMC Medicine;2023-10-25
4. Drug-induced altered self-presentation increases tumor immunogenicity;Biomedicine & Pharmacotherapy;2023-09
5. EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells;Cellular & Molecular Biology Letters;2023-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3